Article Sidebar
Published:
Dec 6, 2016Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Guidelines for the management of asthma in adults in South Africa: Part II. Acute asthma
Abstract
Statement by a working group of the South African Pulmonology Society
The morbidity and mortality caused by asthma can be attributed to three factors: underassessment of severity, failure on the part of both patients and their medical attendants to initiate treatment promptly, and undertreatment of exacerbations; Moreover, most exacerbations can be prevented by use of appropriate long-term
treatment (S Afr Med J 1992; 81: 319-322). The present guidelines are for the care of acute asthma ('asthma attacks') and are intended to encourage a uniform approach to the m.anagement of exacerbations, whether of rapid or gradual onset, mild or severe. They have been developed on the basis of the best available evidence on the efficacy and safety of asthma drugs, and efforts have been made to ensure that recom.m.endations are costeffective and affordable, and may with little modification be applied in all locations: the home (as initial self-management), the clinic with modest facilities, doctors' surgeries, emergency departments and hospitals. The guidelines stress (i) assessment of severity; (ii) recognition of risk; and (iii) stepwise treatm.ent based upon these assessments. Primary therapies are the repeated use of high doses of [β2-agonists and early introduction of corticosteroids.
Specific goals of treatment are to: (i) relieve airway obstruction; (ii) relieve hypoxaemia; (iii) restore lung function to normal as rapidly as possible by reducing airway irritability; (iv) provide a suitable plan to avoid future relapse; and (v) provide a written plan of action to be followed early in future attacks.
Simplified management schemes for different locations are provided as addenda for ease of reference.
